At close: December 13 at 4:00:01 PM EST
After hours: December 13 at 7:48:14 PM EST
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 9 | 6 | 9 | 10 |
| Avg. Estimate | -0.55 | -0.61 | -2.47 | -2.55 |
| Low Estimate | -0.68 | -0.7 | -2.62 | -3.32 |
| High Estimate | -0.39 | -0.55 | -2.32 | -2.23 |
| Year Ago EPS | -0.67 | -0.62 | -2.79 | -2.47 |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 10 | 6 | 12 | 12 |
| Avg. Estimate | 6.08M | 50k | 15.08M | 3.52M |
| Low Estimate | -- | -- | 10M | -- |
| High Estimate | 50M | 200k | 60M | 25M |
| Year Ago Sales | -- | 10.01M | 25.55M | 15.08M |
| Sales Growth (year/est) | 0.00% | -99.50% | -40.98% | -76.68% |
Earnings History
| Currency in USD | 12/31/2023 | 3/31/2024 | 6/30/2024 | 9/30/2024 |
|---|---|---|---|---|
| EPS Est. | -0.77 | -0.69 | -0.73 | -0.78 |
| EPS Actual | -0.67 | -0.62 | -0.69 | -0.63 |
| Difference | 0.1 | 0.07 | 0.04 | 0.15 |
| Surprise % | 12.92% | 9.89% | 5.34% | 19.62% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.55 | -0.61 | -2.47 | -2.55 |
| 7 Days Ago | -0.55 | -0.61 | -2.47 | -2.55 |
| 30 Days Ago | -0.6 | -0.61 | -2.53 | -2.55 |
| 60 Days Ago | -0.76 | -0.76 | -2.86 | -3.1 |
| 90 Days Ago | -0.77 | -0.78 | -2.88 | -3.15 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | 2 | -- | 2 | 2 |
| Up Last 30 Days | 9 | 6 | 9 | 10 |
| Down Last 7 Days | 1 | 1 | 1 | 1 |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| RLAY | 18.19% | 1.08% | 11.49% | -3.17% |
| S&P 500 | 5.00% | 12.00% | 2.10% | 12.20% |
Upgrades & Downgrades
| Reiterates | JMP Securities: Market Outperform to Market Outperform | 12/12/2024 |
| Maintains | Leerink Partners: Outperform to Outperform | 12/5/2024 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 12/4/2024 |
| Maintains | Leerink Partners: Outperform to Outperform | 12/4/2024 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 11/8/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 10/14/2024 |
Related Tickers
BCYC Bicycle Therapeutics plc
13.81
-31.33%
NRIX Nurix Therapeutics, Inc.
20.27
-1.41%
KYMR Kymera Therapeutics, Inc.
42.13
-0.09%
KURA Kura Oncology, Inc.
9.63
-0.62%
RPTX Repare Therapeutics Inc.
1.7700
-55.42%
OLMA Olema Pharmaceuticals, Inc.
6.75
+0.45%
ANAB AnaptysBio, Inc.
15.59
+3.79%
OKUR OnKure Therapeutics, Inc.
9.86
-8.96%
COGT Cogent Biosciences, Inc.
8.15
-2.28%
ARVN Arvinas, Inc.
19.50
-1.22%